Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.9M
-
Number of holders
-
349
-
Total 13F shares, excl. options
-
37M
-
Shares change
-
-367K
-
Total reported value, excl. options
-
$4.32B
-
Value change
-
+$55.2M
-
Put/Call ratio
-
0.72
-
Number of buys
-
189
-
Number of sells
-
-142
-
Price
-
$116.63
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q1 2025
417 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2025.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 349 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37M shares
of 48.9M outstanding shares and own 75.61% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.88M shares), BlackRock, Inc. (3.52M shares), RTW INVESTMENTS, LP (2.92M shares), BVF INC/IL (1.69M shares), FMR LLC (1.25M shares), MACQUARIE GROUP LTD (976K shares), GEODE CAPITAL MANAGEMENT, LLC (935K shares), STATE STREET CORP (906K shares), Invesco Ltd. (857K shares), and Fairmount Funds Management LLC (815K shares).
This table shows the top 349 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.